CASP3 and prostate carcinoma: Interestingly, we found that gDEC inhibited prostate cancer cell growth and proliferation in vitro without activating the apoptotic cascade as measured by apoptotic markers poly (ADP-ribose) polymerase (PARP) and caspase-3 cleavage (Figure S3).